Global Thrombin Market to Reach $793.3 Million by 2030
The global market for Thrombin estimated at US$587 Million in the year 2022, is projected to reach a revised size of US$793.3 Million by 2030, growing at a CAGR of 3.8% over the analysis period 2022-2030. Bovine Thrombin, one of the segments analyzed in the report, is projected to record 4.2% CAGR and reach US$345.1 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Human Thrombin segment is readjusted to a revised 3.4% CAGR for the next 8-year period.
The U.S. Market is Estimated at $175.2 Million, While China is Forecast to Grow at 3.6% CAGR
The Thrombin market in the U.S. is estimated at US$175.2 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$139.8 Million by the year 2030 trailing a CAGR of 3.6% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.6% and 3.2% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 3.9% CAGR.Select Competitors (Total 42 Featured) -
- Baxter
- Bayer
- CSL
- GE Healthcare
- Grifols
- Haematologic Technologies Inc.
- Hualan Biological
- Japan Blood Products Organization
- Johnson & Johnson Services
- Mochida Pharmaceutical Co.
- Octapharma
- Omrix Biopharmaceuticals Ltd.
- Pfizer
- Shanghai RAAS blood products co. Ltd.
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and the publisher's Research Platform
- Complimentary updates for one year
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERSIV. COMPETITION
1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Thrombin - Global Key Competitors Percentage Market Share in 2022 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
- Impact of Covid-19 and a Looming Global Recession
4. GLOBAL MARKET PERSPECTIVE
- Table 1: World Recent Past, Current & Future Analysis for Thrombin by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
- Table 2: World Historic Review for Thrombin by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 3: World 16-Year Perspective for Thrombin by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2023 & 2030
- Table 4: World Recent Past, Current & Future Analysis for Bovine Thrombin by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
- Table 5: World Historic Review for Bovine Thrombin by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 6: World 16-Year Perspective for Bovine Thrombin by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
- Table 7: World Recent Past, Current & Future Analysis for Human Thrombin by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
- Table 8: World Historic Review for Human Thrombin by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 9: World 16-Year Perspective for Human Thrombin by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
- Table 10: World Recent Past, Current & Future Analysis for Recombinant Thrombin by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
- Table 11: World Historic Review for Recombinant Thrombin by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 12: World 16-Year Perspective for Recombinant Thrombin by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
- Table 13: World Recent Past, Current & Future Analysis for Powder Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
- Table 14: World Historic Review for Powder Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 15: World 16-Year Perspective for Powder Form by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
- Table 16: World Recent Past, Current & Future Analysis for Solution Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
- Table 17: World Historic Review for Solution Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 18: World 16-Year Perspective for Solution Form by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
- Table 19: World Recent Past, Current & Future Analysis for Other Dosage Forms by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
- Table 20: World Historic Review for Other Dosage Forms by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 21: World 16-Year Perspective for Other Dosage Forms by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
- Table 22: World Thrombin Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
III. MARKET ANALYSIS
- UNITED STATES
- Thrombin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
- Table 23: USA Recent Past, Current & Future Analysis for Thrombin by Product - Bovine Thrombin, Human Thrombin and Recombinant Thrombin - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 24: USA Historic Review for Thrombin by Product - Bovine Thrombin, Human Thrombin and Recombinant Thrombin Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 25: USA 16-Year Perspective for Thrombin by Product - Percentage Breakdown of Value Sales for Bovine Thrombin, Human Thrombin and Recombinant Thrombin for the Years 2014, 2023 & 2030
- Table 26: USA Recent Past, Current & Future Analysis for Thrombin by Dosage Form - Powder Form, Solution Form and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 27: USA Historic Review for Thrombin by Dosage Form - Powder Form, Solution Form and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 28: USA 16-Year Perspective for Thrombin by Dosage Form - Percentage Breakdown of Value Sales for Powder Form, Solution Form and Other Dosage Forms for the Years 2014, 2023 & 2030
- CANADA
- Table 29: Canada Recent Past, Current & Future Analysis for Thrombin by Product - Bovine Thrombin, Human Thrombin and Recombinant Thrombin - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 30: Canada Historic Review for Thrombin by Product - Bovine Thrombin, Human Thrombin and Recombinant Thrombin Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 31: Canada 16-Year Perspective for Thrombin by Product - Percentage Breakdown of Value Sales for Bovine Thrombin, Human Thrombin and Recombinant Thrombin for the Years 2014, 2023 & 2030
- Table 32: Canada Recent Past, Current & Future Analysis for Thrombin by Dosage Form - Powder Form, Solution Form and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 33: Canada Historic Review for Thrombin by Dosage Form - Powder Form, Solution Form and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 34: Canada 16-Year Perspective for Thrombin by Dosage Form - Percentage Breakdown of Value Sales for Powder Form, Solution Form and Other Dosage Forms for the Years 2014, 2023 & 2030
- JAPAN
- Thrombin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
- Table 35: Japan Recent Past, Current & Future Analysis for Thrombin by Product - Bovine Thrombin, Human Thrombin and Recombinant Thrombin - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 36: Japan Historic Review for Thrombin by Product - Bovine Thrombin, Human Thrombin and Recombinant Thrombin Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 37: Japan 16-Year Perspective for Thrombin by Product - Percentage Breakdown of Value Sales for Bovine Thrombin, Human Thrombin and Recombinant Thrombin for the Years 2014, 2023 & 2030
- Table 38: Japan Recent Past, Current & Future Analysis for Thrombin by Dosage Form - Powder Form, Solution Form and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 39: Japan Historic Review for Thrombin by Dosage Form - Powder Form, Solution Form and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 40: Japan 16-Year Perspective for Thrombin by Dosage Form - Percentage Breakdown of Value Sales for Powder Form, Solution Form and Other Dosage Forms for the Years 2014, 2023 & 2030
- CHINA
- Thrombin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
- Table 41: China Recent Past, Current & Future Analysis for Thrombin by Product - Bovine Thrombin, Human Thrombin and Recombinant Thrombin - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 42: China Historic Review for Thrombin by Product - Bovine Thrombin, Human Thrombin and Recombinant Thrombin Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 43: China 16-Year Perspective for Thrombin by Product - Percentage Breakdown of Value Sales for Bovine Thrombin, Human Thrombin and Recombinant Thrombin for the Years 2014, 2023 & 2030
- Table 44: China Recent Past, Current & Future Analysis for Thrombin by Dosage Form - Powder Form, Solution Form and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 45: China Historic Review for Thrombin by Dosage Form - Powder Form, Solution Form and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 46: China 16-Year Perspective for Thrombin by Dosage Form - Percentage Breakdown of Value Sales for Powder Form, Solution Form and Other Dosage Forms for the Years 2014, 2023 & 2030
- EUROPE
- Thrombin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
- Table 47: Europe Recent Past, Current & Future Analysis for Thrombin by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
- Table 48: Europe Historic Review for Thrombin by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 49: Europe 16-Year Perspective for Thrombin by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2023 & 2030
- Table 50: Europe Recent Past, Current & Future Analysis for Thrombin by Product - Bovine Thrombin, Human Thrombin and Recombinant Thrombin - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 51: Europe Historic Review for Thrombin by Product - Bovine Thrombin, Human Thrombin and Recombinant Thrombin Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 52: Europe 16-Year Perspective for Thrombin by Product - Percentage Breakdown of Value Sales for Bovine Thrombin, Human Thrombin and Recombinant Thrombin for the Years 2014, 2023 & 2030
- Table 53: Europe Recent Past, Current & Future Analysis for Thrombin by Dosage Form - Powder Form, Solution Form and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 54: Europe Historic Review for Thrombin by Dosage Form - Powder Form, Solution Form and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 55: Europe 16-Year Perspective for Thrombin by Dosage Form - Percentage Breakdown of Value Sales for Powder Form, Solution Form and Other Dosage Forms for the Years 2014, 2023 & 2030
- FRANCE
- Thrombin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
- Table 56: France Recent Past, Current & Future Analysis for Thrombin by Product - Bovine Thrombin, Human Thrombin and Recombinant Thrombin - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 57: France Historic Review for Thrombin by Product - Bovine Thrombin, Human Thrombin and Recombinant Thrombin Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 58: France 16-Year Perspective for Thrombin by Product - Percentage Breakdown of Value Sales for Bovine Thrombin, Human Thrombin and Recombinant Thrombin for the Years 2014, 2023 & 2030
- Table 59: France Recent Past, Current & Future Analysis for Thrombin by Dosage Form - Powder Form, Solution Form and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 60: France Historic Review for Thrombin by Dosage Form - Powder Form, Solution Form and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 61: France 16-Year Perspective for Thrombin by Dosage Form - Percentage Breakdown of Value Sales for Powder Form, Solution Form and Other Dosage Forms for the Years 2014, 2023 & 2030
- GERMANY
- Thrombin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
- Table 62: Germany Recent Past, Current & Future Analysis for Thrombin by Product - Bovine Thrombin, Human Thrombin and Recombinant Thrombin - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 63: Germany Historic Review for Thrombin by Product - Bovine Thrombin, Human Thrombin and Recombinant Thrombin Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 64: Germany 16-Year Perspective for Thrombin by Product - Percentage Breakdown of Value Sales for Bovine Thrombin, Human Thrombin and Recombinant Thrombin for the Years 2014, 2023 & 2030
- Table 65: Germany Recent Past, Current & Future Analysis for Thrombin by Dosage Form - Powder Form, Solution Form and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 66: Germany Historic Review for Thrombin by Dosage Form - Powder Form, Solution Form and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 67: Germany 16-Year Perspective for Thrombin by Dosage Form - Percentage Breakdown of Value Sales for Powder Form, Solution Form and Other Dosage Forms for the Years 2014, 2023 & 2030
- ITALY
- Table 68: Italy Recent Past, Current & Future Analysis for Thrombin by Product - Bovine Thrombin, Human Thrombin and Recombinant Thrombin - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 69: Italy Historic Review for Thrombin by Product - Bovine Thrombin, Human Thrombin and Recombinant Thrombin Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 70: Italy 16-Year Perspective for Thrombin by Product - Percentage Breakdown of Value Sales for Bovine Thrombin, Human Thrombin and Recombinant Thrombin for the Years 2014, 2023 & 2030
- Table 71: Italy Recent Past, Current & Future Analysis for Thrombin by Dosage Form - Powder Form, Solution Form and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 72: Italy Historic Review for Thrombin by Dosage Form - Powder Form, Solution Form and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 73: Italy 16-Year Perspective for Thrombin by Dosage Form - Percentage Breakdown of Value Sales for Powder Form, Solution Form and Other Dosage Forms for the Years 2014, 2023 & 2030
- UNITED KINGDOM
- Thrombin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
- Table 74: UK Recent Past, Current & Future Analysis for Thrombin by Product - Bovine Thrombin, Human Thrombin and Recombinant Thrombin - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 75: UK Historic Review for Thrombin by Product - Bovine Thrombin, Human Thrombin and Recombinant Thrombin Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 76: UK 16-Year Perspective for Thrombin by Product - Percentage Breakdown of Value Sales for Bovine Thrombin, Human Thrombin and Recombinant Thrombin for the Years 2014, 2023 & 2030
- Table 77: UK Recent Past, Current & Future Analysis for Thrombin by Dosage Form - Powder Form, Solution Form and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 78: UK Historic Review for Thrombin by Dosage Form - Powder Form, Solution Form and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 79: UK 16-Year Perspective for Thrombin by Dosage Form - Percentage Breakdown of Value Sales for Powder Form, Solution Form and Other Dosage Forms for the Years 2014, 2023 & 2030
- REST OF EUROPE
- Table 80: Rest of Europe Recent Past, Current & Future Analysis for Thrombin by Product - Bovine Thrombin, Human Thrombin and Recombinant Thrombin - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 81: Rest of Europe Historic Review for Thrombin by Product - Bovine Thrombin, Human Thrombin and Recombinant Thrombin Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 82: Rest of Europe 16-Year Perspective for Thrombin by Product - Percentage Breakdown of Value Sales for Bovine Thrombin, Human Thrombin and Recombinant Thrombin for the Years 2014, 2023 & 2030
- Table 83: Rest of Europe Recent Past, Current & Future Analysis for Thrombin by Dosage Form - Powder Form, Solution Form and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 84: Rest of Europe Historic Review for Thrombin by Dosage Form - Powder Form, Solution Form and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 85: Rest of Europe 16-Year Perspective for Thrombin by Dosage Form - Percentage Breakdown of Value Sales for Powder Form, Solution Form and Other Dosage Forms for the Years 2014, 2023 & 2030
- ASIA-PACIFIC
- Thrombin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
- Table 86: Asia-Pacific Recent Past, Current & Future Analysis for Thrombin by Product - Bovine Thrombin, Human Thrombin and Recombinant Thrombin - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 87: Asia-Pacific Historic Review for Thrombin by Product - Bovine Thrombin, Human Thrombin and Recombinant Thrombin Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 88: Asia-Pacific 16-Year Perspective for Thrombin by Product - Percentage Breakdown of Value Sales for Bovine Thrombin, Human Thrombin and Recombinant Thrombin for the Years 2014, 2023 & 2030
- Table 89: Asia-Pacific Recent Past, Current & Future Analysis for Thrombin by Dosage Form - Powder Form, Solution Form and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 90: Asia-Pacific Historic Review for Thrombin by Dosage Form - Powder Form, Solution Form and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 91: Asia-Pacific 16-Year Perspective for Thrombin by Dosage Form - Percentage Breakdown of Value Sales for Powder Form, Solution Form and Other Dosage Forms for the Years 2014, 2023 & 2030
- REST OF WORLD
- Table 92: Rest of World Recent Past, Current & Future Analysis for Thrombin by Product - Bovine Thrombin, Human Thrombin and Recombinant Thrombin - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 93: Rest of World Historic Review for Thrombin by Product - Bovine Thrombin, Human Thrombin and Recombinant Thrombin Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 94: Rest of World 16-Year Perspective for Thrombin by Product - Percentage Breakdown of Value Sales for Bovine Thrombin, Human Thrombin and Recombinant Thrombin for the Years 2014, 2023 & 2030
- Table 95: Rest of World Recent Past, Current & Future Analysis for Thrombin by Dosage Form - Powder Form, Solution Form and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 96: Rest of World Historic Review for Thrombin by Dosage Form - Powder Form, Solution Form and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 97: Rest of World 16-Year Perspective for Thrombin by Dosage Form - Percentage Breakdown of Value Sales for Powder Form, Solution Form and Other Dosage Forms for the Years 2014, 2023 & 2030
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Baxter
- Bayer
- CSL
- GE Healthcare
- Grifols
- Haematologic Technologies Inc.
- Hualan Biological
- Japan Blood Products Organization
- Johnson & Johnson Services
- Mochida Pharmaceutical Co.
- Octapharma
- Omrix Biopharmaceuticals Ltd.
- Pfizer
- Shanghai RAAS blood products co. Ltd.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 194 |
| Published | May 2024 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value ( USD | $ 587 Million |
| Forecasted Market Value ( USD | $ 793.3 Million |
| Compound Annual Growth Rate | 3.8% |
| Regions Covered | Global |
